Evidence map›Paper›PMID 31426299›Full record

Trial reportNutrients2019

Effects of

Åsa Håkansson, Carin Andrén Aronsson, Charlotte Brundin, Elin Oscarsson, Göran Molin, Daniel Agardh

3 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 48 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 6 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03176095 nacompletednot on this map

Celiac Disease Prevention With Probiotics

TypeinterventionalSponsorLund UniversityRan2012 to 2015Enrolled90ConditionsCeliac Disease in ChildrenArmsProbiotic, Placebo
NCT05194033 nacompletednot on this mapstarted 2022, after this paper: background citation

Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination: A Prospective, Randomized, Double-blind, Placebo-Controlled Trial (Trial 1)

TypeinterventionalSponsorPeking UniversityRan2022 to 2022Enrolled31ConditionsSARS-CoV-2ArmsProbiotics daily, Placebo daily
NCT05195047 nacompletednot on this mapstarted 2022, after this paper: background citation

Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination: A Prospective, Randomized, Double-blind, Placebo-Controlled Trial (Trial 2)

TypeinterventionalSponsorPeking UniversityRan2022 to 2022Enrolled44ConditionsSARS-CoV-2Arms1 week placebo(Week 1), 1 week of probiotics(Week 1), 1 week placebo(Week 2), 1 week of probiotics(Week 2), 1 week placebo(Week 3)
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 6 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. The Role ofInternational journal of molecular sciences · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. The role of probiotics in the immune response and intestinal microbiota of children with celiac disease: a systematic review.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2021
    Pooled it
  6. Meta-Analysis: Randomized Trials ofFrontiers in immunology · 2021
    Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Review
  11. Article
  12. Effect of Probiotics ContainingFoods (Basel, Switzerland) · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Celiac Disease: A Review from Genetic to Treatment.Iranian biomedical journal · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Åsa HåkanssonDepartment of Food Technology Engineering and Nutrition, Lund University, Box 124, 22100 Lund, Sweden.
Carin Andrén AronssonThe Diabetes and Celiac Disease Unit, Department of Clinical Sciences, Lund University, 21428 Malmö, Sweden.ORCID 0000-0003-0256-9367
Charlotte BrundinThe Diabetes and Celiac Disease Unit, Department of Clinical Sciences, Lund University, 21428 Malmö, Sweden.
Elin OscarssonThe Diabetes and Celiac Disease Unit, Department of Clinical Sciences, Lund University, 21428 Malmö, Sweden.
Göran MolinDepartment of Food Technology Engineering and Nutrition, Lund University, Box 124, 22100 Lund, Sweden.
Daniel AgardhThe Diabetes and Celiac Disease Unit, Department of Clinical Sciences, Lund University, 21428 Malmö, Sweden. daniel.agardh@med.lu.se.ORCID 0000-0003-1435-1234
Lund University · SE

Funding

ALF projektmedel 20141120ALF projektmedel 2018 på 5 år 20181031Crafords stiftelse 20160530Dr Per Håkanssons stiftelse 20150508Dr Per Håkanssons stiftelse 20160513FoU projektmedel 20161027FoU Region Skåne 20152016SUS fonder 20150515SUS fonder 20160616Svenska Läkaresällskapet Ihres fond 20150615Svenska Läkaresällskapet projektmedel 20150615Swedish Celiac Disease Foundation 20150615Swedish Research Council 20151029Swedish Research Council 20181026
6 · The paper itself

Abstract

Two

Indexed as

Lacticaseibacillus paracaseiLactiplantibacillus plantarumAutoantibodiesCeliac DiseaseChildChild, PreschoolDouble-Blind MethodFemaleGTP-Binding ProteinsHumansMaleProbioticsProtein Glutamine gamma Glutamyltransferase 2TransglutaminasesAutoantibodiesGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2Transglutaminasesautoimmunityceliac diseaseimmune functionprobiotic

Identifiers

PMID31426299
PMCPMC6723580
OpenAlexW2967843024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.